EDAP TMS reported EUR61.46M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
AngioDynamics USD 269.68M 4.04M Sep/2025
Boston Scientific USD 43.67B 966M Dec/2025
EDAP TMS EUR 61.46M 6.88M Sep/2025
Henry Schein USD 11.22B 118M Dec/2025
Medtronic USD 91.48B 139M Dec/2025
Plus Therapeutics USD 16.32M 2.34M Dec/2025
Veracyte USD 1.41B 38.23M Dec/2025